Location permission needed for a better experience.
EN
CV
MEMBERSHIPS
PUBLICATIONS
EDUCATION
  • 2017 Acıbadem Üniversitesi Tıp Fakültesi / Profesör Doktor
  • 2010 Ufuk Üniversitesi Tıp Fakültesi / Doçent Doktor
  • 2009 University of Michigan School of Medicine / Hepatoloji Uzmanlığı
  • 2005 Gazi Üniversitesi Tıp Fakültesi Gastroenteroloji
  • 2001 Gazi Üniversitesi Tıp Fakültesi İç Hastalıkları
  • 1996 Gazi Üniversitesi Tıp Fakültesi
EXPERIENCE
  • 2012 Acıbadem Sağlık Grubu
  • 2012 Acıbadem Üniversitesi Tıp Fakültesi Gastroenteroloji Bilim Dalı Öğretim Üyesi-Halen
  • 2009 - 2012 Ufuk Üniversitesi / Gastroenteroloji Bilim Dalı Öğretim Üyesi
  • 2006 - 2009 University of Michigan / Division of Gastroenterology and Hepatology
  • 2005 - 2006 Ankara Gülhane Askeri Tıp Akademisi / Gastroenteroloji Bilim Dalı
  • 2002 - 2005 Gazi Üniversitesi Tıp Fakültesi / Gastroenteroloji Uzmanlığı
  • 1997 - 2001 Gazi Üniversitesi Tıp Fakültesi / İç Hastalıkları Uzmanlığı
MEMBERSHIPS
  • Türk Gastroenteroloji Derneği
  • Türkiye Karaciğer Araştırmaları Derneği
  • European Association for the Study of the Liver (EASL)
  • Türk Motilite Derneği
  • Türk Tabipleri Birliği
  • Türk Obezite Derneği
  • Gastrointestinal Endoskopi Derneği
PUBLICATIONS
  • The Changing Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Turkey in the Last Decade Turk J Gastroenterol. 2021 Mar;32(3):302-312. Değertekin B, Tozun N, Demir F, Söylemez G, Parkan Ş, Gürtay E, Mutlu D, Toraman M, Seymenoğlu TH
  • Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience Turk J Gastroenterol. 2020 Dec;31(12):883-893. Değertekin B, Demir M, Akarca US, Kani HT, Üçbilek E, Yıldırım E, Güzelbulut F, Balkan A, Vatansever S, Danış N, Demircan M, Soylu A, Yaras S, Kartal
  • Regular coffee intake improves liver enzyme levels and liver histology in patients with chronic alcohol consumption, non-alcoholic fatty liver and non-alcoholic steatohepatitis: Report of 259 cases Hepatology Forum.2020: 88-96. Bulent Degertekin, Nurdan Tozun, Aysegul Gizem Soylemez, Ezgi Gurtay, Ugur Bozkurt, Yusuf Yilmaz, Suna Yapali, Eser Vardareli, Hakan Umit Unal
  • Determination of the upper limits of normal serum alanine aminotransferase (ALT) level in healthy Turkish population Hepatology Forum 2020:44-47 Bulent Degertekin, Nurdan Tozun, Figen Demir, Gizem Soylemez, Suna Yapali, Ugur Bozkurt, Ezgi Gurtay, Tolga Hayrettin Seymenoglu, Deniz Mutlu,
  • VH.Diagnosis, management and treatment of hepatitis delta virus infection: Turkey 2017 Clinical Practice Guidelines Turk J Gastroenterol. 2017 Dec;28(Suppl 2):84-89. Yurdaydın C, Tabak F, Kaymakoğlu S, Akarsu M, Akıncı EG, Akkız H, Alkım C, Çekin AH, Çuvalcı NÖ, Demir K, Değertekin B, Dökmetaş İ, Ersöz G, Hizel K,
  • VH.Diagnosis, management and treatment of hepatitis B virus infection: Turkey 2017 Clinical Practice Guidelines Turk J Gastroenterol. 2017 Dec;28(Suppl 2):73-83 Tabak F, Yurdaydın C, Kaymakoğlu S, Akarsu M, Akıncı EG, Akkız H, Alkım C, Çekin AH, Çuvalcı NÖ, Demir K, Değertekin B, Dökmetaş İ, Ersöz G, Hizel K,
  • Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference J Viral Hepat. 2016 Feb;23 Suppl 1:1-12. Papatheodoridis G, Thomas HC, Golna C, Bernardi M, Carballo M, Cornberg M, Dalekos G, Degertekin B, Dourakis S, Flisiak R, Goldberg D, Gore C, Goulis
  • The relationship between heterotopic gastric mucosa in the cervical esophagus and laryngopharyngeal reflux Kulak Burun Bogaz Ihtis Derg. 2012 Jan-Feb;22(1):6-11. Ezerarslan H, Çoban M, Kuran S, Akmansu ŞH, Özgüler Z, Beriat GK, Erkan G, Değertekin B, Kocatürk S
  • A Burkitt''s Lymphoma Case Mimicking Crohn''s Disease: A Case Report Case Report Med. 2011;2011:685273. Erkan G, Coban M, Calıskan A, Ataç GK, Gulpınar K, Degertekin B, Korkmaz A.
  • Clinical outcomes of liver transplantation for HBV-related hepatocellular carcinoma: data from the NIH HBV OLT study Clin Transplant. 2011 Mar-Apr;25(2):E152-62. Han SH, Reddy KR, Keeffe EB, Soldevila-Pico C, Gish R, Chung RT, Degertekin B, Lok A; NIH HBV OLT Study Group

INFORMATION FORM WITH REGARD TO OBTAINING AND PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. (“Acıbadem”) and Acıbadem’s controlling shareholders, parent companies and affiliates (hereinafter to be collectively referred to as “Acıbadem Group”) may, acting as “Data Supervisor” under the Law on Protection of Personal Data no. 6698 (the “Law”) and other pertinent laws and regulations, process your personal data within the following frame and in strict compliance with the Basic Healthcare Services Law no. 3359, the Governmental Decree-Law on Organization and Duties of the Ministry of Health and its Affiliated Companies no. 663, the Private Hospitals Regulation, and other regulations of the Ministry of Health, and other applicable laws and provisions.

1. Obtaining and Processing of Personal Data, and Purposes of Processing:

Your personal data is collected and obtained verbally, in writing, or in visual or electronic media, through call center, internet site, verbally, in writing or similar other channels for conduct of such services as protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services offered by Acıbadem Group, or for planning and management of healthcare services and financing, and in accordance with the fields of business of Acıbadem Group Companies. Your general personal data and special personal data, especially your healthcare data, may be processed by the Group to a limited extent for all and any purposes, including, but not limited to, the following purposes:

All kinds of your personal data obtained by Acıbadem Group (including, but not limited to, your special personal data) may be processed for the following purposes:

Your personal data obtained and processed pursuant to the applicable laws and regulations may be transferred to physical archives and/or information systems of Acıbadem or Acıbadem Group and may be kept and stored both in digital and in physical platforms.

2. Transfer of Personal Data

Your personal data may be shared by Acıbadem and Acıbadem Group with companies included in Acıbadem Group or with private insurance companies, Ministry of Health and its sub-units, Social Security Agency, Security General Directorate and other security forces, General Directorate of Population and Census, Turkish Pharmacists’ Association, courts and all kinds of other juridical authorities, central etc. third parties, your authorized representatives and agents, and third parties offering consulting and advice services to us, including, but not limited to, lawyers, tax and financial consultants and auditors, and our business partners and other third parties acting in cooperation with us for further development or performance of healthcare services for the purposes cited above, also including regulatory and supervisory bodies and authorities, and official authorities, for the purposes of processing listed above, in accordance with the Law and other applicable laws and regulations.

3. Methods and Legal Causes of Obtaining of Personal Data

Your personal data are collected and processed in all kinds of verbal, written, visual or electronic media, for the purposes listed hereinabove, and for performance of all kinds of works included in the fields of business of Acıbadem within the legal framework, and accordingly, for full and proper performance of all kinds of contractual and legal duties and obligations of Acıbadem. Legal causes of collection and acquisition of your personal data are the pertinent provisions of:

Furthermore, as stipulated in 3rd paragraph of article 6 of the Law, personal data relating to health may also be processed by persons under secrecy obligations or by authorized official entities and organizations, without being liable to receive prior explicit consent of the relevant purpose, only for protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services, and for planning and management of healthcare services and financing.

4. Your Rights Regarding Protection of Personal Data

Pursuant to the Law and other relevant applicable laws and regulations, you are entitled:

If at any time you use any one or more of your aforesaid rights, the relevant information will be transmitted to you clearly and in an understandable manner, in writing or in electronic media, by using the communication data and information provided by you.

5. Data Security

Acıbadem protects your personal data in full and strict compliance with all technical and administrative security controls required to be taken in accordance with information security standards and procedures. Said security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

6. Complaints and Communications

Your personal data are protected within the frame of the available technical and administrative possibilities, and the required security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

By filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the , “https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html” web address, you may transmit and submit your legal requests:

You are hereby kindly requested to transmit your legal requests under the Law by filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html web address and sending it to us by the communication means set forth in the form.

TOP
How can we help you?